Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.1 CAD | -0.55% | +12.62% | -39.97% |
Chart calendar Fennec Pharmaceuticals Inc.
Upcoming events on Fennec Pharmaceuticals Inc.
Past events on Fennec Pharmaceuticals Inc.
25/06/2024 07:30 pm | Annual General Meeting |
14/05/2024 06:00 pm | Q1 2024 Earnings Call |
14/05/2024 03:33 pm | Q1 2024 Earnings Release |
21/03/2024 06:00 pm | Q4 2023 Earnings Call |
21/03/2024 03:30 pm | Q4 2023 Earnings Release |
16/11/2023 03:30 pm | Jefferies London Healthcare Conference |
16/11/2023 | Craig-Hallum Alpha Select Conference |
06/11/2023 07:00 pm | Q3 2023 Earnings Call |
06/11/2023 04:29 pm | Q3 2023 Earnings Release |
28/09/2023 12:30 am | Cantor Global Healthcare Conference |
12/09/2023 11:00 pm | H.C. Wainwright Global Investment Conference |
08/08/2023 | Wedbush PacGrow Healthcare Conference |
03/08/2023 06:00 pm | Q2 2023 Earnings Call |
03/08/2023 03:29 pm | Q2 2023 Earnings Release |
12/06/2023 07:30 pm | Annual General Meeting |
11/05/2023 06:00 pm | Q1 2023 Earnings Call |
11/05/2023 03:31 pm | Q1 2023 Earnings Release |
30/03/2023 03:25 pm | Q4 2022 Earnings Release |
11/11/2022 05:40 pm | Q3 2022 Earnings Release |
12/08/2022 04:29 pm | Interim 2022 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,17 0,00 - | 0,00 0,00 - | 1,54 0,74 106.09% | 21,3 20,5 3.76% | 62,9 |
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 -6,00 - | 24,3 |
EBIT Million USD | Released Forecast Spread | -13,0 -11,7 -11.27% | -17,9 -20,1 11.12% | -17,2 -17,6 2.15% | -22,6 -23,7 4.68% | -12,8 -11,0 -16.58% | 17,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,8 -11,5 -11.55% | -18,1 -20,4 11.25% | -17,3 -17,5 0.99% | -23,7 -24,3 2.4% | -12,8 -8,58 -48.81% | 13,7 |
Net income Million USD | Released Forecast Spread | -12,8 -11,5 -11.55% | -18,1 -20,4 11.25% | -17,3 -17,5 0.99% | -23,7 -24,3 2.4% | -16,0 -8,59 -86.8% | 14,6 |
EPS USD | Released Forecast Spread | -0,64 -0,55 -16.36% | -0,76 -0,86 11.63% | -0,67 -0,67 0% | -0,90 -0,92 1.82% | -0,60 -0,53 -14.07% | 0,51 |
Announcement Date | 14/02/20 | 30/03/21 | 28/02/22 | 29/03/23 | 21/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 1,54 0,74 106.09% | 1,68 1,85 -9.18% | 3,33 3,73 -10.82% | 6,52 5,34 22.08% | 9,74 8,97 8.54% | 25,4 18,9 34.4% | 11,0 | 11,9 | 14,6 | 16,3 | 15,8 |
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,40 | 3,00 | 5,50 | 15,0 | 7,30 | ||||||||
EBIT Million USD | Released Forecast Spread | -3,55 -3,66 3.13% | -5,01 -3,56 -40.64% | -7,90 -4,81 -64.11% | -6,14 -7,24 15.31% | -5,27 -5,03 -4.72% | -4,67 -3,90 -19.51% | -1,02 -2,84 64.2% | -1,82 -0,36 -401.17% | 13,7 6,29 118.47% | -0,25 | 0,77 | 2,78 | 4,96 | 1,82 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,70 -3,65 -1.26% | -5,07 -3,58 -41.87% | -8,09 -4,85 -66.66% | -6,86 -7,37 6.91% | -6,05 -5,76 -5.14% | -5,44 -4,28 -27.12% | -1,87 -3,27 42.82% | -1,82 -0,47 -283.06% | 12,8 6,97 84.1% | -0,76 | -0,29 | 1,85 | 4,10 | 1,01 |
Net income Million USD | Released Forecast Spread | -3,70 -3,65 -1.26% | -5,07 -3,58 -41.87% | -8,09 -4,85 -66.66% | -6,86 -7,37 6.91% | -6,05 -5,76 -5.14% | -5,44 -4,28 -27.12% | -1,87 -3,27 42.82% | -2,68 -0,48 -456.43% | 12,8 5,71 124.63% | -0,82 | 0,25 | 2,29 | 3,70 | 0,81 |
EPS USD | Released Forecast Spread | -0,14 -0,14 0% | -0,19 -0,14 -39.02% | -0,31 -0,18 -70.64% | -0,26 -0,27 1.89% | -0,23 -0,21 -9.52% | -0,21 -0,16 -34.04% | -0,07 -0,12 41.67% | -0,10 -0,02 -400% | 0,41 0,21 92.19% | -0,03 | 0,01 | 0,08 | 0,11 | 0,09 |
Announcement Date | 12/05/22 | 12/08/22 | 11/11/22 | 29/03/23 | 11/05/23 | 03/08/23 | 06/11/23 | 21/03/24 | 14/05/24 | - | - | - | - | - |
Past sector events for Fennec Pharmaceuticals Inc.
12/07/2024 01:30 am | NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release |
09/07/2024 | LUMOSA THERAPEUTICS CO., LTD.: June 2024 Sales and Revenue Release |
08/07/2024 | TAIMED BIOLOGICS INC.: June 2024 Sales and Revenue Release |
05/07/2024 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
07/06/2024 | LUMOSA THERAPEUTICS CO., LTD.: May 2024 Sales and Revenue Release |
07/06/2024 | TAIMED BIOLOGICS INC.: May 2024 Sales and Revenue Release |
05/06/2024 01:21 pm | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
16/05/2024 05:16 pm | BIOCON LIMITED: Q4 2024 Earnings Release |
16/05/2024 10:30 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- FENC Stock
- FRX Stock
- Calendar Fennec Pharmaceuticals Inc.